2BB score and signals
Oruka Therapeutics, Inc.’s current 2BB score is 19 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 35 | Low |
| Momentum | 8 | Strongly Weakening |
| Financial strength | 32 | Weak |
| Quality | 80 | Very Strong |
| Risk | 51 | Moderate |
Company facts
| Headquarters | Westminster, Colorado, United States |
| Founded | 2024 |
| Employees | 68 |
| 52-week range | $14.61 – $115.51 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-10 | — | -0.5997 | — | $0.00 |
| 2026-08-10 | -0.55 | -0.5257 | $0.00 | $0.00 |
| 2026-05-13 | -0.48 | -0.5602 | $0.00 | $0.00 |
| 2026-03-12 | -0.45 | -0.64 | $0.00 | $0.00 |
Related companies
2BBBullish & Bearish